Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -14.07% is 35% above its 5-year average of -21.80%, near the high end of its 5-year range (-57.45%–2.92%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.47% below its 12-month average of -13.09%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -14.07%.
RETURN ON EQUITY (ROE)
-14.07%
RETURN ON EQUITY (ROE) AVG TTM
-13.09%
RETURN ON EQUITY (ROE) AVG 3Y
-28.50%
RETURN ON EQUITY (ROE) AVG 5Y
-21.80%
RETURN ON EQUITY (ROE) AVG 10Y
-3.45%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-7.47%
CURRENT VS 3Y AVG
+50.66%
CURRENT VS 5Y AVG
+35.49%
CURRENT VS 10Y AVG
-307.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.89%
median of 686 covered companies
CURRENT VS SECTOR MEDIAN
+65.60%
vs the sector median at left
Inogen, Inc.
Market Cap
$157.03M
Return on Equity (ROE)
-14.07%
TTM Avg
-13.09%
3Y Avg
-28.50%
5Y Avg
-21.80%
Market Cap
$155.68M
Return on Equity (ROE)
-170.49%
TTM Avg
-166.01%
3Y Avg
-121.36%
5Y Avg
-104.96%
Market Cap
$155.86M
Return on Equity (ROE)
N/A
TTM Avg
13.51%
3Y Avg
15.58%
5Y Avg
15.05%
Market Cap
$158.40M
Return on Equity (ROE)
N/A
TTM Avg
101.44%
3Y Avg
117.16%
5Y Avg
-25.56%
Market Cap
$152.06M
Return on Equity (ROE)
-59.40%
TTM Avg
-255.06%
3Y Avg
-160.44%
5Y Avg
-112.56%
Market Cap
$159.91M
Return on Equity (ROE)
-215.26%
TTM Avg
-150.35%
3Y Avg
8.65%
5Y Avg
-35.35%
Market Cap
$161.16M
Return on Equity (ROE)
-60.19%
TTM Avg
-68.34%
3Y Avg
-61.91%
5Y Avg
-47.91%
Market Cap
$151.15M
Return on Equity (ROE)
-93.22%
TTM Avg
-92.28%
3Y Avg
-73.94%
5Y Avg
-53.80%
Market Cap
$151.58M
Return on Equity (ROE)
-155.34%
TTM Avg
-168.75%
3Y Avg
-117.97%
5Y Avg
-104.46%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inogen, Inc. (INGN) | $157.03M | -14.07% | -13.09% | -28.50% | -21.80% |
| Neuronetics, Inc. (STIM)vs › | $155.68M | -170.49% | -166.01% | -121.36% | -104.96% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | 13.51% | 15.58% | 15.05% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.40M | N/A | 101.44% | 117.16% | -25.56% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $152.06M | -59.40% | -255.06% | -160.44% | -112.56% |
| Coherus Oncology, Inc. (CHRS)vs › | $159.91M | -215.26% | -150.35% | 8.65% | -35.35% |
| PepGen Inc. (PEPG)vs › | $161.16M | -60.19% | -68.34% | -61.91% | -47.91% |
| Codexis, Inc. (CDXS)vs › | $151.15M | -93.22% | -92.28% | -73.94% | -53.80% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | -155.34% | -168.75% | -117.97% | -104.46% |
| Quanterix Corporation (QTRX)vs › | $163.27M | -51.90% | -23.95% | -20.95% | -18.62% |
ROE
-14.1%
ROA
-8.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -14.07% |
| 2026-03-31 | -13.61% |
| 2025-12-31 | -11.83% |
| 2025-09-30 | -12.87% |
| 2025-06-30 | -13.06% |
| 2025-03-31 | -13.88% |
| 2024-12-31 | -20.64% |
| 2024-09-30 | -28.42% |
| 2024-06-30 | -49.28% |
| 2024-03-31 | -50.38% |
| 2023-12-31 | -50.02% |
| 2023-09-30 | -57.45% |
| 2023-06-30 | -35.04% |
| 2023-03-31 | -31.96% |
| 2022-12-31 | -28.17% |
| 2022-09-30 | -14.26% |
| 2022-06-30 | -7.95% |
| 2022-03-31 | -5.53% |
| 2021-12-31 | -1.71% |
| 2021-09-30 | 2.92% |
| 2021-06-30 | -0.66% |
| 2021-03-31 | -1.40% |
| 2020-12-31 | -1.67% |
| 2020-09-30 | -0.59% |
| 2020-06-30 | 1.85% |
| 2020-03-31 | 4.05% |
| 2019-12-31 | 6.08% |
| 2019-09-30 | 9.43% |
| 2019-06-30 | 12.56% |
| 2019-03-31 | 14.41% |
| 2018-12-31 | 16.70% |
| 2018-09-30 | 14.14% |
| 2018-06-30 | 12.03% |
| 2018-03-31 | 10.48% |
| 2017-12-31 | 9.25% |
| 2017-09-30 | 12.14% |
| 2017-06-30 | 11.06% |
| 2017-03-31 | 10.27% |
| 2016-12-31 | 8.91% |
| 2016-09-30 | 9.50% |
| 2016-06-30 | 9.53% |
| 2016-03-31 | 8.96% |
| 2015-12-31 | 8.64% |
| 2015-09-30 | 7.12% |
| 2015-06-30 | 6.79% |
| 2015-03-31 | 6.13% |
| 2014-12-31 | 5.78% |
| 2014-09-30 | 23.95% |
| 2014-06-30 | 23.39% |
| 2014-03-31 | 23.72% |
| 2013-12-31 | 45.18% |
| 2013-09-30 | 10.45% |
| 2013-06-30 | 4.30% |
